Tiffany A Freed

Tiffany A Freed is an accomplished inventor based in Apex, NC (US). She has made significant contributions to the field of mass spectrometry, particularly in the detection and quantitation of metabolites related to kidney and liver functions. With a total of 2 patents, her work is paving the way for advancements in metabolic health assessments.

Latest Patents

Freed's latest patents include a mass spectrometry assay method for the detection and quantitation of kidney function metabolites. This innovative method allows for the determination of various analytes, such as N-acetylthreonine, creatinine, and urea, by subjecting samples to an ionization source. The process measures the amount of ions produced and uses this data to quantify the analytes present in the sample. Additionally, she has developed a similar method for liver function metabolites, which includes analytes like 3-hydroxybutyrate and gamma-tocopherol. Both patents emphasize the importance of accurate metabolic assessments and include kits with isotopically labeled analogues as internal standards.

Career Highlights

Freed is currently employed at Metabolon, Inc., where she continues to innovate in the field of mass spectrometry. Her work is instrumental in enhancing the understanding of metabolic processes and their implications for health.

Collaborations

Some of her notable coworkers include Lisa Ford and Kelsey M Eason, who contribute to the collaborative environment at Metabolon, Inc. Their teamwork fosters innovation and drives research forward.

Conclusion

Tiffany A Freed's contributions to mass spectrometry and her innovative patents are vital for advancing metabolic health assessments. Her work exemplifies the impact of scientific research on improving health outcomes.

Profile summary based on public USPTO records.